DHC
Diversified Healthcare TrustBDocument history
Earnings documents stored for DHC.
Investor releaseQuarter not tagged2026-08-04Diversified Healthcare Trust Q2 2026 Earnings Call Summary
Moby
Diversified Healthcare Trust Q2 2026 Earnings Call Summary
Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Management attributes the 20.4% year-over-year consolidated NOI growth to successful business plan execution following the completion of senior housing operator transitions in late 2025. The SHOP segment's 37.2% same-property NOI increase was driven by a combination of 160 basis points in occupancy gains and a 6.2% rise in average monthly rates. Profitability is currently outperforming original underwriting due to an accelerated capture of higher acuity care levels and rapid realization of expense synergies by new operators. Management noted that while occupancy volume is pacing slightly below initial projections, the 'structural margin enhancements' are fully offsetting top-line volume moderation. The company is leveraging a regionalized community oversight model to share best practices, which has directly contributed to significant margin expansion. Operational focus has shifted from large-scale capital recycling to improving organic operations and identifying high-return internal redevelopment projects. The Medical Office and Life Science portfolio remains stable with 95.8% occupancy, though management is proactively addressing three known tenant vacates representing 4.6% of segment revenue. Full-year 2026 SHOP NOI guidance assumes a 200 basis point occupancy growth and 5.5% average monthly rate growth, reflecting a more disciplined approach to profitability over pure volume. Management expects to commence new legacy operator contracts in January 2027, transitioning them to a highly aligned fee structure with lower base fees and performance-based tiers. A $20 million initial investment in SHOP repositioning is expected to convert closed skilled nursing wings into 150 revenue-generating units by the second half of 2027. The company anticipates annualized cost savings of $14 million to $16 million from new food and beverage contracts, with approximately $8 million of that benefit recognized in 2026. Future capital allocation will prioritize deleveraging and internal high-return projects, with the Board reviewing the potential for dividend adjustments on a quarterly basis. Second quarter G&A expense included a $10 million incentive management fee driven by DHC's significant total shareholder return outperfor…Read full documentShow less
Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Management attributes the 20.4% year-over-year consolidated NOI growth to successful business plan execution following the completion of senior housing operator transitions in late 2025. The SHOP segment's 37.2% same-property NOI increase was driven by a combination of 160 basis points in occupancy gains and a 6.2% rise in average monthly rates. Profitability is currently outperforming original underwriting due to an accelerated capture of higher acuity care levels and rapid realization of expense synergies by new operators. Management noted that while occupancy volume is pacing slightly below initial projections, the 'structural margin enhancements' are fully offsetting top-line volume moderation. The company is leveraging a regionalized community oversight model to share best practices, which has directly contributed to significant margin expansion. Operational focus has shifted from large-scale capital recycling to improving organic operations and identifying high-return internal redevelopment projects. The Medical Office and Life Science portfolio remains stable with 95.8% occupancy, though management is proactively addressing three known tenant vacates representing 4.6% of segment revenue. Full-year 2026 SHOP NOI guidance assumes a 200 basis point occupancy growth and 5.5% average monthly rate growth, reflecting a more disciplined approach to profitability over pure volume. Management expects to commence new legacy operator contracts in January 2027, transitioning them to a highly aligned fee structure with lower base fees and performance-based tiers. A $20 million initial investment in SHOP repositioning is expected to convert closed skilled nursing wings into 150 revenue-generating units by the second half of 2027. The company anticipates annualized cost savings of $14 million to $16 million from new food and beverage contracts, with approximately $8 million of that benefit recognized in 2026. Future capital allocation will prioritize deleveraging and internal high-return projects, with the Board reviewing the potential for dividend adjustments on a quarterly basis. Second quarter G&A expense included a $10 million incentive management fee driven by DHC's significant total shareholder return outperformance. A $2.3 million non-cash share-based compensation charge was recorded, with more than half representing a one-time expense for accelerated vesting of awards. SHOP same-store NOI included a $1.5 million one-time expense benefit related to timing of accruals that is not expected to recur in the third quarter. The Medical Office segment recorded a $1 million one-time bad debt charge in the second quarter, which was unrelated to the previously disclosed upcoming tenant vacancies. One stock. Nvidia-level potential. 30M+ investors trust Moby to find it first. Get the pick. Tap here. Management clarified that the slower occupancy ramp-up is a function of 'transition noise' as new operators rebuild local sales teams and leadership infrastructure. The delay is characterized as a timing issue rather than a lack of demand or a failure to hit specific occupancy levers. The new contracts will cover the remaining 80-plus communities not included in the Aleris transition, effectively standardizing the entire portfolio under an aligned fee framework. The shift aims to provide immediate cost savings of approximately $2 million annually through tighter cost controls and reduced base fees. Management expects additional synergies in 2027 as legacy operators adopt the new contract structures and dietary/maintenance savings continue to materialize. Current expense improvements are supported by prior capital expenditures that have reduced ongoing maintenance requirements. While tracking toward the high end of guidance, management expects typical third-quarter seasonality related to increased utility costs. The company remains comfortable with current RevPOR growth trajectories and expects consistent performance to carry into 2027.
Investor releaseQuarter not tagged2026-08-04Diversified Healthcare Trust Q2 Earnings Call Highlights
MarketBeat
Diversified Healthcare Trust Q2 Earnings Call Highlights
Interested in Diversified Healthcare Trust? Here are five stocks we like better. Strong second-quarter performance: Diversified Healthcare Trust’s consolidated NOI rose 20.4% year over year to $84 million, driven by a 37.2% increase in same-property SHOP NOI. Senior housing occupancy and rates improved, while procurement and operating efficiencies supported margins despite a slower-than-expected occupancy ramp. Growth initiatives are advancing: DHC is renegotiating legacy SHOP operator agreements expected to deliver nearly $2 million in annual savings starting in 2027. It also plans to invest about $20 million to redevelop six communities, adding roughly 150 senior housing units beginning in late 2027. Guidance and balance sheet improved: The company reaffirmed its 2026 outlook, with adjusted EBITDARE of $300 million to $315 million and normalized FFO of $0.56 to $0.62 per share. Net debt to annualized adjusted EBITDARE fell to 7.1 times from 8.7 times a year earlier, supported by asset sales and stronger operations. Diversified Healthcare Trust (NASDAQ:DHC) reported second-quarter results marked by higher senior housing profitability, continued occupancy and pricing gains, and reduced leverage, while reaffirming the full-year guidance it raised in June. Normalized funds from operations totaled $39 million, or $0.16 per share, in the second quarter, while adjusted EBITDARE was $82 million. Consolidated net operating income rose 20.4% year over year to $84 million, according to President and Chief Executive Officer Chris Bilotto. → SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control The company’s senior housing operating portfolio, or SHOP segment, remained the principal source of growth. Same-property SHOP NOI increased 37.2% year over year to $52 million, supported by a 160-basis-point increase in occupancy to 83.1%, a 6.2% gain in average monthly rates and margin expansion. Bilotto said the company’s operator transitions, completed in late 2025, are beginning to produce benefits from more regional oversight and shared operating practices. However, management said occupancy growth and related revenue are tracking slightly below its initial 2026 expectations because of the timing required to rebuild local leadership, sales teams and operating infrastructure at transitioned communities. → Financials Hit Record Highs as the AI Trad…Read full documentShow less
Interested in Diversified Healthcare Trust? Here are five stocks we like better. Strong second-quarter performance: Diversified Healthcare Trust’s consolidated NOI rose 20.4% year over year to $84 million, driven by a 37.2% increase in same-property SHOP NOI. Senior housing occupancy and rates improved, while procurement and operating efficiencies supported margins despite a slower-than-expected occupancy ramp. Growth initiatives are advancing: DHC is renegotiating legacy SHOP operator agreements expected to deliver nearly $2 million in annual savings starting in 2027. It also plans to invest about $20 million to redevelop six communities, adding roughly 150 senior housing units beginning in late 2027. Guidance and balance sheet improved: The company reaffirmed its 2026 outlook, with adjusted EBITDARE of $300 million to $315 million and normalized FFO of $0.56 to $0.62 per share. Net debt to annualized adjusted EBITDARE fell to 7.1 times from 8.7 times a year earlier, supported by asset sales and stronger operations. Diversified Healthcare Trust (NASDAQ:DHC) reported second-quarter results marked by higher senior housing profitability, continued occupancy and pricing gains, and reduced leverage, while reaffirming the full-year guidance it raised in June. Normalized funds from operations totaled $39 million, or $0.16 per share, in the second quarter, while adjusted EBITDARE was $82 million. Consolidated net operating income rose 20.4% year over year to $84 million, according to President and Chief Executive Officer Chris Bilotto. → SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control The company’s senior housing operating portfolio, or SHOP segment, remained the principal source of growth. Same-property SHOP NOI increased 37.2% year over year to $52 million, supported by a 160-basis-point increase in occupancy to 83.1%, a 6.2% gain in average monthly rates and margin expansion. Bilotto said the company’s operator transitions, completed in late 2025, are beginning to produce benefits from more regional oversight and shared operating practices. However, management said occupancy growth and related revenue are tracking slightly below its initial 2026 expectations because of the timing required to rebuild local leadership, sales teams and operating infrastructure at transitioned communities. → Financials Hit Record Highs as the AI Trade Unravels—Can They Keep Leading? “This isn’t a function in our view of hitting certain occupancy levels,” Bilotto said in response to an analyst question. “It’s just a delay in the timing of that ramp up.” Management said the slower occupancy ramp is being offset by better-than-expected profitability per occupied unit. Higher-acuity care revenue, ancillary revenue and expense efficiencies have supported revenue per occupied room and expense performance. → Why Rare Earth Processing Could Be the Real 2027 Opportunity Anthony Paula, vice president, said same-property SHOP occupancy increased 70 basis points sequentially during the quarter, while average monthly rates rose 100 basis points sequentially and 620 basis points year over year. In-property expense per occupied room declined 170 basis points from the first quarter and increased 150 basis points from the prior year. The company cited new food-and-beverage procurement contracts among the cost-saving measures. Paula said those agreements are expected to produce annualized savings of $14 million to $16 million, including about $8 million expected to be recognized during 2026. Second-quarter SHOP NOI also included about $1.5 million of one-time expense benefits related to timing of expense recognition and first-quarter overaccruals, CFO and Treasurer Matt Brown said. The benefit is not expected to recur in the third quarter. DHC is renegotiating contracts with its legacy SHOP operators, seeking to align them with the framework used for recently transitioned communities. The revised agreements are expected to include lower base fees, incentive fees tied to annual operational performance and tighter cost controls. Bilotto said the agreements are expected to generate immediate annual cost savings of nearly $2 million before potential incentive-fee-related growth. The new contracts are expected to begin in January 2027 and cover the remainder of the portfolio outside of communities transitioned from the former AlerisLife arrangement. The company also continues to pursue redevelopment opportunities at 16 SHOP communities, where closed skilled nursing wings or floors could be converted into independent living, assisted living and memory care units. DHC plans an initial investment of about $20 million at six communities to add roughly 150 units. Construction on the initial phase is expected to begin later this year, with the first units scheduled to come online in the second half of 2027. Management expects the projects to generate unlevered returns in the mid-teens while converting carrying costs on closed space into revenue-producing units. In DHC’s medical office and life science portfolio, same-property occupancy increased 110 basis points year over year to 95.8%. The company completed approximately 477,000 square feet of new and renewal leasing during the quarter, with a 6.7% rent roll-up and a weighted-average lease term of 7.1 years. Same-property NOI in the segment was $24.1 million, essentially unchanged from a year earlier. Brown said second-quarter rental revenue was affected by a one-time bad-debt charge of about $1 million that was unrelated to upcoming vacancies. The company has three known tenant departures representing approximately 4.6% of the segment’s expiring annualized revenue. Two tenants vacated July 1, accounting for 3.5% of annualized revenue and 213,000 square feet, while another tenant is expected to leave Dec. 1. DHC plans to market one 150,000-square-foot property for sale and is marketing the other two properties for lease. DHC ended the quarter with $267 million of liquidity, including $117 million of cash and an undrawn $150 million secured revolving credit facility. Net debt to annualized adjusted EBITDARE declined to 7.1 times from 8.7 times a year earlier, helped by SHOP performance and more than $600 million of asset sales completed since the beginning of 2025. Interest coverage improved to 2.2 times from 1.4 times in the prior-year period. The company’s next debt maturity is not until February 2028, Brown said. The company reaffirmed its 2026 outlook: Total NOI of $307 million to $323 million. SHOP NOI of $185 million to $195 million. Adjusted EBITDARE of $300 million to $315 million. Normalized FFO of $0.56 to $0.62 per share. While retaining its SHOP NOI forecast, DHC lowered its occupancy-growth assumption to 200 basis points and its revenue-growth assumption to 6.6%. It raised its average monthly rate growth assumption to 5.5% and reduced its operating expense growth assumption to 2.5%, reflecting stronger-than-expected cost controls. Brown said SHOP NOI is tracking toward the high end of the company’s June guidance range, though DHC expects some third-quarter utility-cost seasonality. The company also reaffirmed recurring capital expenditure guidance of $100 million to $115 million for 2026. Bilotto said DHC’s capital recycling program is substantially complete and that the company is focused on operations, deleveraging and internal investment opportunities. He added that the board reviews the dividend quarterly as the company evaluates options to enhance shareholder returns. Diversified Healthcare Trust is a real estate investment trust (REIT) specializing in the acquisition, ownership and management of healthcare properties across the United States. The company focuses on assets that serve the senior housing and post-acute care sectors, including skilled nursing facilities, assisted living communities, memory care centers and medical office buildings. By partnering with experienced operators, Diversified Healthcare Trust aims to generate stable, long-term cash flows through triple-net leases and percentage rent structures tailored to each property type. The company's portfolio spans multiple states and encompasses a mix of single-tenant and multi-tenant properties. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. The article "Diversified Healthcare Trust Q2 Earnings Call Highlights" was originally published by MarketBeat. View MarketBeat's top stocks for August 2026.
Investor releaseQuarter not tagged2026-08-04Diversified Healthcare Trust (DHC) (Q2 2026) Earnings Call Highlights: SHOP NOI Surges 37% as ...
GuruFocus.com
Diversified Healthcare Trust (DHC) (Q2 2026) Earnings Call Highlights: SHOP NOI Surges 37% as ...
This article first appeared on GuruFocus. Normalized FFO: $39 million, or $0.16 per share. Adjusted EBITDA RE: $82 million. Consolidated NOI: Increased 20.4% year-over-year to $84 million. SHOP Same-Property NOI: Increased 37.2% year-over-year to $52 million. SHOP Same-Property Occupancy: Increased 160 basis points year-over-year to 83.1%. SHOP Average Monthly Rate: Increased 6.2% year-over-year. Medical Office and Life Science Same-Property Occupancy: Increased 110 basis points year-over-year to 95.8%. Medical Office and Life Science Same-Property NOI: $24.1 million, essentially flat year-over-year. Leasing Activity: Approximately 477,000 square feet of new and renewal leasing at a 6.7% rent rollup. Liquidity: Approximately $267 million at quarter end. Net Debt to Adjusted EBITDA RE: 7.1 times, down from 8.7 times in the prior year. Adjusted EBITDA RE to Interest Expense: Improved to 2.2 times from 1.4 times in the prior year. G&A Expense: $7.1 million for the quarter, excluding a $10 million incentive management fee and $2.3 million of non-cash share-based compensation. Capital Expenditures: $25.8 million invested in the quarter, including $19.1 million in SHOP communities and $6.7 million in medical office and life science portfolio. Warning! GuruFocus has detected 6 Warning Signs with DHC. Is DHC fairly valued? Test your thesis with our free DCF calculator. Release Date: August 04, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Diversified Healthcare Trust (NASDAQ:DHC) reported strong second quarter results, with normalized FFO of $39 million and consolidated NOI increasing 20.4% year-over-year, exceeding analyst estimates. SHOP segment same-property NOI surged 37.2% year-over-year, driven by a 160 basis point occupancy increase, a 6.2% rise in average monthly rate, and continued margin expansion. The company is renegotiating legacy operator contracts to align with a more favorable fee structure, expected to deliver immediate annual cost savings of nearly $2 million starting in January 2027. DHC is executing a $20 million repositioning plan to convert closed skilled nursing wings into high-demand senior housing units, projected to generate mid-teens unlevered returns and add roughly 150 units. Leverage improved significantly, with net debt to EBITDA down to 7.1 times from 8.7 times year-over-year…Read full documentShow less
This article first appeared on GuruFocus. Normalized FFO: $39 million, or $0.16 per share. Adjusted EBITDA RE: $82 million. Consolidated NOI: Increased 20.4% year-over-year to $84 million. SHOP Same-Property NOI: Increased 37.2% year-over-year to $52 million. SHOP Same-Property Occupancy: Increased 160 basis points year-over-year to 83.1%. SHOP Average Monthly Rate: Increased 6.2% year-over-year. Medical Office and Life Science Same-Property Occupancy: Increased 110 basis points year-over-year to 95.8%. Medical Office and Life Science Same-Property NOI: $24.1 million, essentially flat year-over-year. Leasing Activity: Approximately 477,000 square feet of new and renewal leasing at a 6.7% rent rollup. Liquidity: Approximately $267 million at quarter end. Net Debt to Adjusted EBITDA RE: 7.1 times, down from 8.7 times in the prior year. Adjusted EBITDA RE to Interest Expense: Improved to 2.2 times from 1.4 times in the prior year. G&A Expense: $7.1 million for the quarter, excluding a $10 million incentive management fee and $2.3 million of non-cash share-based compensation. Capital Expenditures: $25.8 million invested in the quarter, including $19.1 million in SHOP communities and $6.7 million in medical office and life science portfolio. Warning! GuruFocus has detected 6 Warning Signs with DHC. Is DHC fairly valued? Test your thesis with our free DCF calculator. Release Date: August 04, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Diversified Healthcare Trust (NASDAQ:DHC) reported strong second quarter results, with normalized FFO of $39 million and consolidated NOI increasing 20.4% year-over-year, exceeding analyst estimates. SHOP segment same-property NOI surged 37.2% year-over-year, driven by a 160 basis point occupancy increase, a 6.2% rise in average monthly rate, and continued margin expansion. The company is renegotiating legacy operator contracts to align with a more favorable fee structure, expected to deliver immediate annual cost savings of nearly $2 million starting in January 2027. DHC is executing a $20 million repositioning plan to convert closed skilled nursing wings into high-demand senior housing units, projected to generate mid-teens unlevered returns and add roughly 150 units. Leverage improved significantly, with net debt to EBITDA down to 7.1 times from 8.7 times year-over-year, and liquidity stands at $267 million, providing financial flexibility. The company reaffirmed its full-year guidance, with SHOP NOI tracking towards the high end, supported by expense synergies such as new food and beverage contracts yielding $14-16 million in annualized savings. SHOP occupancy growth is pacing below initial 2026 projections, with average occupancy growth guidance reduced by 100 basis points to 200 basis points, reflecting a slower-than-expected ramp-up. Revenue growth in the SHOP segment was revised down by 140 basis points to 6.6%, indicating top-line momentum is temporarily muted due to transition-related disruptions. The company noted a one-time benefit of $1.5 million in Q2 SHOP NOI from expense timing that will not repeat in Q3, potentially impacting sequential performance. Medical office and life science segment NOI was essentially flat year-over-year, with known tenant vacates representing 4.6% of annualized revenue, including two that vacated in July. G&A expenses included a $10 million incentive management fee and $2.3 million in non-cash share-based compensation, with over half of the latter being a one-time accelerated vesting expense. The company faces ongoing challenges in fully integrating new operators, with sales teams and infrastructure still being rebuilt, which has delayed occupancy gains. Q: Can you provide additional color on why the SHOP topline is tracking below expectations, and is this mainly driven by a slower leasing season or something more temporary?A: Christopher Bilotto, President and CEO, attributed the slower pace to "transition noise" from operator changes. New operators have spent the last six months rebuilding local leadership and sales teams. These teams are now largely in place, and benefits are starting to flow through, but the pace of occupancy growth is expected to be somewhat muted in the near term. He remains bullish on the long-term outlook for driving occupancy. Q: Is the lower RevPAR driven by the occupancy uptick, or did you have to be more judicious on increasing rates for existing residents due to the transitions?A: CEO Christopher Bilotto clarified that total RevPOR is actually increasing. The decrease in total revenue is tied to occupancy levels. The company is seeing strong uptake in ancillary revenues and higher acuity care levels, which is driving outsized results in RevPOR. As occupancy ramps, they expect to recapture the incremental revenue. Q: On the expense side, is the benefit from new group contracts a good baseline going forward, or is there more benefit moving into 2017?A: CFO Matthew Brown stated that the new guidance is a good run rate for the end of this year. However, they expect additional synergies moving into 2027, both from new operators and from expected changes to legacy operator management contracts. For 2026, they are seeing significant savings in dietary, maintenance, and contract labor. Q: Regarding the new management agreements starting in 2027, are there opportunities for additional agreement changes longer-term, or does this encompass the entire portfolio?A: CEO Christopher Bilotto confirmed that once these new agreements are in place, they will encompass the entire portfolio, covering the balance of 80-plus communities outside of the Aleris transition. He does not anticipate major changes to the contracts in the near term, though they are evaluating other opportunities related to operators. Q: Can you provide color on the $1.5 million of one-time expense benefits in the quarter that won't roll forward?A: CFO Matthew Brown explained that it was due to the timing of expense recognition, specifically over-accruals in the first quarter that were offset in the second quarter. Q: Given the strong 1H SHOP NOI performance, are you tracking towards the high end of guidance, and is there any seasonality to be aware of in 3Q or 4Q?A: CFO Matthew Brown confirmed they are tracking to the high end of guidance. They expect a little bit of seasonality in the third quarter related to increases in utilities, but nothing overly material. Overall, they feel good about the high end of the guidance. Q: You've already achieved a rate growth of close to 6% in 1H, but guidance is 5.5% for the full year. Any reason not to raise that further?A: CEO Christopher Bilotto stated they are comfortable with the current trajectory and are being mindful of the many moving pieces related to transitions. He believes there is a reasonable expectation to continue the run rate into 2027 with consistent growth across the portfolio. Q: Is the lower occupancy guidance a result of new operators not chasing expensive occupancy, or is it just a timing issue?A: CEO Christopher Bilotto indicated it is a timing issue, not a lack of focus on top-line growth. The guidance reflects average occupancy growth for the year, and they still feel good about real growth by year-end. There are also other upsides from levels of care and ancillary revenue that will continue to drive performance. Q: What drove the quarter-over-quarter decline in MOB Life Science rental revenue?A: CFO Matthew Brown noted there was a one-time bad debt charge of about $1 million impacting Q2 results. This was unrelated to the upcoming vacancies. For the complete transcript of the earnings call, please refer to the full earnings call transcript.
TranscriptFY2026 Q22026-08-04FY2026 Q2 earnings call transcript
Earnings source - 47 paragraphs
FY2026 Q2 earnings call transcript
Good morning, and welcome to the Diversified Healthcare Trust second quarter 2026 earnings conference call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on a touch-tone phone. To withdraw your question, please press star then two. Please note this event is being recorded. I would now like to turn the call over to Matt Murphy, Manager of Investor Relations. Please go ahead.
Good morning. Joining me on today's call are Chris Bilotto, President and Chief Executive Officer, Matt Brown, Chief Financial Officer and Treasurer, and Anthony Paula, Vice President. Today's call includes a presentation by management, followed by a question-and-answer session with sell-side analysts. Please note that the recording and retransmission of today's conference call is strictly prohibited without the prior written consent of the company. Today's conference call contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws. These forward-looking statements are based upon DHC's beliefs and expectations as of today, Tuesday, August 4th, 2026. The company undertakes no obligation to revise or publicly release the results of any revision to the forward-looking statements made in today's conference call, other than through filings with the Securities and Exchange Commission or SEC.
This call may contain non-GAAP numbers, including Normalized FFO, NOI, and Cash Basis NOI. A reconciliation of these non-GAAP measures to net income is available in our financial results package, which can be found on our website at www.dhcreit.com. Actual results may differ materially from those projected in any forward-looking statements. Additional information concerning factors that could cause those differences is contained in our filings with the SEC. Investors are cautioned not to place undue reliance upon any forward-looking statements. Finally, we will be providing guidance on this call, including NOI.
We are not providing a reconciliation of these non-GAAP measures as part of our guidance, because certain information required for such reconciliation is not available without unreasonable efforts or at all, such as gains and losses or impairment charges related to the disposition of real estate. With that, I would now like to turn the call over to Chris.
Thank you, Matt. Good morning, everyone, and thank you for joining our call today. DHC delivered impressive second quarter results that exceeded analyst estimates, highlighted by continued operating momentum across the portfolio. The strategic changes we have implemented within our SHOP segment over the past year continue to drive improved profitability. As I will highlight shortly, we believe there is meaningful upside to our current results as new initiatives we are implementing with our operators gain traction. Turning to the quarter. After the market closed yesterday, DHC reported Normalized FFO of $39 million, or $0.16 per share, and Adjusted EBITDARE of $82 million. Consolidated NOI increased 20.4% year over year to $84 million. Beginning with our SHOP segment, same property NOI increased 37.2% year over year to $52 million.
This was driven by a 160 basis point increase in same property occupancy to 83.1%, a 6.2% increase in average monthly rate and continued margin expansion. These strong results highlight solid business plan execution by our senior housing partners. Given that operator transitions were completed in late 2025, DHC remains in the early innings of benefiting from more regionalized community oversight and shared best practices. Our agreements are structured to ensure mutual success, and our continued margin expansion clearly demonstrates the effectiveness of this approach. Turning to our outlook. We are pleased to reaffirm our recently raised full-year guidance and continue to identify additional growth initiatives as we make our way through the year. As we progress, however, the key contributors of our NOI growth continue to evolve alongside the rapid ramp-up of our operators.
As Matt will highlight, while average occupancy and corresponding revenue are pacing slightly below our initial 2026 projections, the profitability of each occupied unit is currently outperforming our original underwriting. To be clear, the pacing and occupancy gains is strictly a function of timing, and we continue to see steady month-over-month improvement. This is largely attributed to the foundational work of rebuilding local leadership and sales teams in conjunction with the operator transitions and establishing essential infrastructure across the transition portfolio. This process made meaningful progress throughout the second quarter. Simultaneously, our profitability outperformance is being driven by an accelerated capture of higher acuity care levels and the rapid realization of expense synergies by our operators, resulting in notable improvements in RevPOR and ExpPOR expectations. The temporary moderation in our top-line volume is being fully offset by these structural margin enhancements.
This dynamic directly protects our bottom line, validates our transition strategy, and continues to position our assets for sustained long-term growth. Looking ahead, we are focused on additional opportunities to improve performance across our SHOP segment. Following the success we have achieved from the new operator agreements, we are currently renegotiating our contracts with our legacy operator base to bring them more in line with our upgraded operator framework. Specifically, these new contracts will transition our legacy partners to a highly aligned fee structure. This includes lower base fees coupled with a tier fee structure tied directly to annual operational outperformance. Furthermore, the updated agreements will introduce tighter, more disciplined cost controls to ensure baseline efficiency. We expect the new contract to provide immediate cost savings of close to $2 million annually before consideration of further growth driven through the incentive fee structure.
These updated agreements are expected to commence in January 2027. We continue to make progress on the repositioning opportunities we discussed last quarter. As a reminder, we identified 16 SHOP communities with the potential to convert closed skilled nursing wings or floors into high-demand independent living, assisted living, and memory care units. We plan to initially spend approximately $20 million on six of these communities, which will add roughly 150 units to our SHOP portfolio. Importantly, given that we are currently absorbing the carrying costs of these closed wings, completing these conversions will transition carrying cost headwinds into revenue-generating units, providing further uplift to our SHOP margins and overall profitability. We believe these projects represent an attractive use of DHC's capital and should generate unlevered mid-teens returns while also improving the overall marketability of these communities.
We anticipate the initial phase of construction to begin later this year, with the first deliveries of these new units coming online in the second half of 2027. Turning to our Medical Office and Life Science portfolio. During the second quarter, same-property occupancy increased 110 basis points year-over-year to 95.8%. Leasing activity remained healthy with approximately 477,000 square feet of new and renewal leasing at a 6.7% rent roll-up and a weighted average lease term of 7.1 years. Same-property NOI in this segment was $24.1 million, essentially flat with last year. As discussed in prior quarters, we have three known vacates representing roughly 4.6% of the segment's expiring annualized revenue. Two of these tenants vacated effective July 1st, representing 3.5% of annualized revenue and 213,000 square feet, with the remaining tenant vacating effective December 1st.
We plan to market for sale one of these properties representing 150,000 square feet and are actively marketing for lease the two remaining properties. We look forward to providing updates on the progress of each of these next quarter. Turning to capital allocation and the balance sheet. We ended the quarter with approximately $267 million of liquidity and materially improved our leverage over the past year to 7.1 times net debt to EBITDA from 8.7 times. We have also significantly improved our interest coverage and strengthened our outlook with the rating agencies. With DHC's large-scale capital recycling program substantially complete, our focus is squarely on improving operations, reducing leverage, and identifying the best uses for our growing free cash flow. What makes our investment thesis so compelling today is that our path to substantial earnings growth is entirely organic, with significant upside already embedded within our existing portfolio.
Beyond maintaining liquidity for high-return internal projects such as our SHOP redevelopments and continued deleveraging, our strengthening balance sheet provides flexibility to evaluate broader strategies to enhance shareholder returns, including revisiting the dividend, which the board reviews quarterly. In conclusion, our second quarter results demonstrate meaningful progress on improving operations, driving SHOP NOI margins higher, and strengthening our financial position. We remain confident in our outlook for the remainder of 2026 and continue to believe the actions we have taken over the past two years will continue to deliver strong returns and create value for our shareholders. With that, I will turn the call over to Anthony.
Thank you, Chris, and good morning, everyone. During the second quarter, our consolidated same-property Cash Basis NOI was $83 million, representing a 20.2% increase year-over-year and 9.3% increase sequentially. These increases are driven by continued robust growth in our SHOP segment as same-property NOI increased 37.2% year-over-year and 17.3% sequentially. Our operators continue to be a major factor in driving the improvement in SHOP NOI by managing expenses while also increasing occupancy and pricing. As an example of this disciplined expense management, we work with our operators to procure new food and beverage contracts. These new contracts have led to many optimization and reduced fees. We anticipate annualized cost savings of $14 million-$16 million, of which approximately $8 million is expected to be recognized this year and is included in our revised guidance provided in June.
In-property ExpPOR decreased 170 basis points sequentially, and grew just 150 basis points year-over-year, which is in line with our revised full-year guidance assumptions that Matt will highlight shortly. During the quarter, same-property occupancy grew 70 basis points sequentially and 160 basis points year-over-year. We also continue to see strong momentum in pricing, with same-property average monthly rate increasing 100 basis points sequentially and 620 basis points year-over-year. DHC shares continue to deliver among the highest total shareholder returns across all REITs in the U.S. over both the past one year and three-year measurement periods. Year-to-date alone, DHC's stock price has appreciated 81.7% versus an 11% gain in the S&P 500 and a 23% gain in the MSCI US REIT/Health Care REIT Index. As a result of this outperformance, our second quarter G&A expense includes approximately $10 million of incentive management fees.
Second quarter G&A also includes $2.3 million of non-cash share-based compensation, more than half of which represents a one-time expense for the accelerated vesting of previously granted share awards, with the remainder consistent with prior-year periods. Excluding the incentive fee and these non-cash items, G&A expense was $7.1 million for the quarter. During the quarter, we invested $25.8 million of capital, including $19.1 million into our SHOP communities and $6.7 million into our Medical Office and Life Science portfolio. Our year-to-date spend of $47.6 million represents a reduction of $18.4 million, or approximately 28%, when compared to the same period in 2025. Our capital expenditures are in line with our expectations, and as a result, we are reaffirming our 2026 recurring CapEx guidance of $100 million-$115 million. I'll turn the call over to Matt.
Thanks, Anthony, and good morning, everyone. As highlighted by Chris and Anthony, our second quarter results continue to show the cash-generating ability of our business, embedded growth in our SHOP segment, and reduced leverage. At quarter end, we had total liquidity of $267 million, including $117 million of cash and our undrawn $150 million secured revolving credit facility. Net debt to annualized Adjusted EBITDARE was 7.1 times at quarter end, a 1.6 times year-over-year, and 0.7 times sequential leverage reduction. This was driven primarily by continued strong performance in our SHOP segment and over $600 million of asset sales completed since the beginning of 2025. We expect our leverage to continue to decrease given the favorable trends at our senior living communities and primarily fixed rate debt profile. Adjusted EBITDARE to interest expense improved meaningfully to 2.2 times from 1.4 times in the prior-year.
As a reminder, our next debt maturity is not until February 2028. With growing SHOP NOI, decreasing leverage, and a portfolio of over $4 billion of unencumbered assets, we believe we have numerous options available to us as this maturity approaches. In June, we increased each of our SHOP NOI, Adjusted EBITDARE, and Normalized FFO guidance by $10 million at the midpoint. Today, we are reaffirming this guidance as follows: total NOI of $307 million-$323 million, including $185 million-$195 million of SHOP NOI, Adjusted EBITDARE of $300 million-$315 million and Normalized FFO of $0.56-$0.62 per share. While our SHOP NOI guidance remains unchanged, we have updated our assumptions as follows. Occupancy growth of 200 basis points, a reduction of 100 basis points.
Revenue growth of 6.6%, a reduction of 140 basis points, partially offset by average monthly rate growth of 5.5%, an increase of 20 basis points. These revenue changes are offset as we have seen meaningful expense control from our new operators. Assumptions include operating expense growth of 2.5%, a reduction of 200 basis points, and ExpPOR growth of 1.5%, a reduction of 70 basis points. Our second quarter results were consistent with the outlook we laid out when we raised guidance in June, and today's reaffirmation reflects that performance combined with our expectations for the remainder of the year. Our second quarter SHOP same store NOI of $52 million included a one-time benefit of approximately $1.5 million related to expenses that we do not expect to see repeated in Q3. These expense one-time benefits contributed 50 basis points of margin in the quarter.
We are encouraged by our results so far in 2026, particularly the continued growth in SHOP NOI, which is tracking towards the high end of our June guidance. Our new operators continue to drive margin expansion through a combination of revenue growth and expense discipline, and we remain confident in the years ahead. That concludes our prepared remarks. Operator, please open the line for questions.
Thank you. We will now begin the question and answer session. To ask a question, you may press star then one on your touch tone phone. If you are using a speakerphone, please pick up your handset before pressing the keys. If at any time your question has been addressed and you would like to withdraw your question, please press star and then two. At this time, I'll pause momentarily to assemble the roster. The first question will come from Michael Carroll with RBC Capital Markets. Please go ahead.
Thanks, Chris. I know you touched on this in your prepared remarks, but I wanted to know if you can give us some additional color on why the SHOP top line is tracking below your expectations. I mean, it sounds like this is mainly driven by just the lower occupancy uptick. Are you just seeing slower trends in the key leasing season that's driving that? Or is there something more temporary or one-off that's holding that back, at least here in the near term?
A lot of it is just kind of more attributed to kind of the transition noise. I think one thing that's important to note is when these communities were transitioned, it wasn't uncommon that many of the operators took on kind of the existing operations infrastructure and team members, and over the course of the last 6 months have continued to kind of rework that. I think where it's most relevant with respect to the portfolio is in kind of the sales teams and those programs. So those are largely now in place and we're seeing kind of the benefit of some of that occupancy flow through as we've seen in the Q2 results. Nonetheless, the pace of where we think that growth will occur is going to be somewhat muted.
So this isn't a function in our view of hitting kind of certain occupancy levels. It's just a kind of a delay in the timing of that ramp up. So I think overall, we remain bullish on our outlook for driving occupancy across the portfolio, and again, kind of have the tools and the resources in place to do that.
Okay, what's the lower RevPOR driven by? Is it kind of tied within the occupancy uptick, or did you have to also be a little bit more judicious on increasing rates to your existing residents because of these transitions?
Total RevPOR is actually increasing, that in itself is not going down. I think maybe total revenue is what you're referring to, where there's a decrease, and that's tied to the occupancy. Where we're getting better RevPOR throughout the portfolio is outside of just work that's being done and opportunities identified through driving occupancy, we're also seeing a good pace and uptick in other ancillary revenues in the level of care, which is driving outsized results with respect to how that informs RevPOR. I think that will continue to pace accordingly, then as occupancy ramps, we'll start to recapture that incremental revenue.
Okay, great. On the ExpPOR side, I know that has been reduced or improved. I think you highlighted just due these new group contracts that these new operators have been able to obtain. Within guidance, moving into 2027, is there more benefit related to that, or is this a good baseline and they've already seen the benefits of getting those new contracts and the new ExpPOR run rate is a good base growing going forward?
I think for now, the new guidance is a good run rate, at least through the end of this year. We are expecting additional synergies as we move into 2027, both in the new operators and even in some of the legacy operators with expected changes to the management contracts for those. We are, for 2026, seeing significant savings in dietary. We've seen maintenance come down significantly, and that's a function of the CapEx we've put into these communities over the last several years. Some other wins we're seeing in contract labor, et cetera.
Okay, great. Thank you.
Again, if you have a question, please press star and then one. The next question will come from John Massocca with B. Riley. Please go ahead.
Good morning. Maybe starting off with the new management agreements that are going to start in 2027 that you announced. Is there opportunities, as you're thinking longer term for additional agreement changes, or does that pretty much encompass the entire portfolio once that's in place?
Once that's in place, that will encompass the entire portfolio. Really, just to kind of go back a little bit, this is all of the agreements, outside of those that were transitioned with the AlerisLife contract. That'll be the balance of 80 plus communities. I don't anticipate any major changes to the contracts in the near term. There are additional opportunities we're evaluating that is more related to kind of the operators and kind of how we think about opportunities there. The contract itself, I think, would roll forward in any particular type of relationship.
Yeah. Then in the quarter, you mentioned $1.5 million of benefits to expenses you don't expect to roll forward. Can you provide a little color on what those were?
Sure. It was really just the timing of expense recognition. We had some over accruals in the first quarter that were offset in the second quarter. That's really the noise from the quarter.
Okay. I guess kind of even factoring that in, if I look at kind of 1H SHOP NOI performance, it kind of feels like if you continue with any kind of a growth trajectory that you saw from 1Q to 2Q, that you're getting towards or above the high end of the new guidance. Anything to kind of be aware of seasonality wise in 3Q or 4Q that would cause you to kind of keep guidance in place? I know it was relatively recently updated, but just was kind of curious if there's something to be aware of beyond those one time expense savings.
Sure. To your point, yes, we are tracking to the high end of guidance. We do expect a little bit of seasonality in the third quarter, related to just increases in utilities, but nothing overly material. Overall, we still feel good about kind of the high end of that guidance as of now.
Okay. Maybe kind of a similar question on rate. It feels like 5.5 for the full year, but you've already done somewhere closer to six in 1H. Any kind of reason not to raise that further? Are you kind of laughing tougher comps in 2H? Was just curious if there's any kind of color around that.
No, I mean, look, I think just being comfortable with kind of where the trajectory is we're trying to be mindful. I think that the key theme here, at least for us this quarter, is there's just a lot of moving pieces, all for the positive in many ways with respect to these transitions. I think as time progresses, we're just kind of unpacking other parts of the business and opportunities. Again, I think for the revised guidance on kind of the rate or RevPOR growth, I think we feel comfortable with where that is. At the same time, I think that there's a reasonable expectation that we can kind of continue that run rate as we go into 2027 with seeing consistent growth across the portfolio. I think, again, I think we feel good about where that number is.
Okay. In terms of the occupancy guidance, holistically speaking, is maybe a way to view it that the new operators are kind of not chasing expensive occupancy, if you will? Or is it, to your point, is it just kind of a focus is maybe more on the expense side for them today and less on the kind of top-line growth side and that will come in time? I'm just kind of curious if it's more like a dynamic of how these operators think about the business or if it's something that's just kind of a timing of getting their kind of teeth fully into these new locations.
I think it's the latter, right? I don't think there's any delay in focus on driving top line. Just a reminder, this is average occupancy growth for the year, so this is a combination of kind of a 12-month trajectory. We still feel good around, as we get to the end of the year, around there being kind of real growth throughout the portfolio. Those things kind of remain, even with this revised guidance. There's a certain communities that we have as identified as kind of more focus-related communities, where we can drive outsized occupancy. There's opportunities, with kind of the teams that I referenced earlier, kind of getting integrated in these communities. Outside of just the occupancy side, as I referenced, there's also other upside we're seeing with levels of care and ancillary revenue, which is also gonna continue to drive performance.
Okay. Last one for me, just kind of switching away from the SHOP portfolio. What drove the kind of quarter-over-quarter decline in MOB Life Science rental revenue? It seems like a lot of the vacancy is gonna hit in 3Q, so just was curious if there's something else going on there.
Sure. We had a one-time bad debt charge, in the quarter, of about $1 million that was impacting Q2 results.
Is that related at all to these upcoming vacancies, or is that a separate credit event?
Unrelated.
Okay. That's it for me. Thank you very much.
Again, if you have a question, please press star and then one. Please stand by as we poll for questions. Showing no further questions, this will conclude our question and answer session. I would like to turn the conference back over to Chris Bilotto, President and Chief Executive Officer, for any closing remarks.
Thank you for joining our call today. Please reach out to our investor relations team if you're interested in scheduling a call with the DHC management. Thank you.
The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.
Investor releaseQuarter not tagged2026-08-03Diversified Healthcare: Q2 Earnings Snapshot
Associated Press
Diversified Healthcare: Q2 Earnings Snapshot
NEWTON, Mass. (AP) — NEWTON, Mass. (AP) — Diversified Healthcare Trust (DHC) on Monday reported a key measure of profitability in its second quarter. The Newton, Massachusetts-based real estate investment trust said it had funds from operations of $38.9 million, or 16 cents per share, in the period. Funds from operations is a closely watched measure in the REIT industry. It takes net income and adds back items such as depreciation and amortization. The company said it had net income that was breakeven. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DHC at https://www.zacks.com/ap/DHC
Investor releaseQuarter not tagged2026-08-03Diversified Healthcare Trust Announces Second Quarter 2026 Results
Business Wire
Diversified Healthcare Trust Announces Second Quarter 2026 Results
Provides Updated Full Year 2026 Financial Guidance NEWTON, Mass., August 03, 2026--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) today announced its financial results for the quarter ended June 30, 2026, and provided updated full year 2026 financial guidance, which can be found at the Quarterly Reports section of DHC's website at https://www.dhcreit.com/investors/financial-information/quarterly/default.aspx. The updated full year 2026 financial guidance is consistent with DHC's news release issued on June 1, 2026. A conference call to discuss DHC's second quarter 2026 financial results will be held on Tuesday, August 4, 2026 at 10:00 a.m. Eastern Time. The conference call may be accessed by dialing (877) 329-4297 or (412) 317-5435 (if calling from outside the United States and Canada); a pass code is not required. A replay will be available for one week by dialing (855) 669-9658; the replay pass code is 4724843. A live audio webcast of the conference call will also be available in a listen-only mode on DHC's website, at www.dhcreit.com. The archived webcast will be available for replay on DHC's website after the call. The transcription, recording and retransmission in any way of DHC's second quarter conference call are strictly prohibited without the prior written consent of DHC. About Diversified Healthcare Trust: DHC is a real estate investment trust focused on owning high-quality healthcare properties located throughout the United States. DHC’s portfolio is anchored by a strategically curated mix of senior housing, medical office and life science assets that combine high quality care, modern technology and amenity rich environments to meet rising demand across the healthcare continuum. As of June 30, 2026, DHC’s approximately $6.3 billion portfolio included 285 properties in 33 states and Washington, D.C., with 23,797 senior living units, approximately 5.6 million square feet of medical office and life science properties and occupied by approximately 250 tenants. DHC is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with over $37 billion in assets under management as of June 30, 2026 and 40 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquartered in Newton, MA. For more information, visit www.dhcreit.com. A Maryland Real Estate Inve…Read full documentShow less
Provides Updated Full Year 2026 Financial Guidance NEWTON, Mass., August 03, 2026--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) today announced its financial results for the quarter ended June 30, 2026, and provided updated full year 2026 financial guidance, which can be found at the Quarterly Reports section of DHC's website at https://www.dhcreit.com/investors/financial-information/quarterly/default.aspx. The updated full year 2026 financial guidance is consistent with DHC's news release issued on June 1, 2026. A conference call to discuss DHC's second quarter 2026 financial results will be held on Tuesday, August 4, 2026 at 10:00 a.m. Eastern Time. The conference call may be accessed by dialing (877) 329-4297 or (412) 317-5435 (if calling from outside the United States and Canada); a pass code is not required. A replay will be available for one week by dialing (855) 669-9658; the replay pass code is 4724843. A live audio webcast of the conference call will also be available in a listen-only mode on DHC's website, at www.dhcreit.com. The archived webcast will be available for replay on DHC's website after the call. The transcription, recording and retransmission in any way of DHC's second quarter conference call are strictly prohibited without the prior written consent of DHC. About Diversified Healthcare Trust: DHC is a real estate investment trust focused on owning high-quality healthcare properties located throughout the United States. DHC’s portfolio is anchored by a strategically curated mix of senior housing, medical office and life science assets that combine high quality care, modern technology and amenity rich environments to meet rising demand across the healthcare continuum. As of June 30, 2026, DHC’s approximately $6.3 billion portfolio included 285 properties in 33 states and Washington, D.C., with 23,797 senior living units, approximately 5.6 million square feet of medical office and life science properties and occupied by approximately 250 tenants. DHC is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with over $37 billion in assets under management as of June 30, 2026 and 40 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquartered in Newton, MA. For more information, visit www.dhcreit.com. A Maryland Real Estate Investment Trust with transferable shares of beneficial interest listed on the Nasdaq.No shareholder, Trustee or officer is personally liable for any act or obligation of the Trust. View source version on businesswire.com: https://www.businesswire.com/news/home/20260803450003/en/ Contacts Bryan Maher, Senior Vice President(617) 796-8234
Investor releaseQuarter not tagged2026-07-09Diversified Healthcare Trust Announces Quarterly Dividend on Common Shares
Business Wire
Diversified Healthcare Trust Announces Quarterly Dividend on Common Shares
NEWTON, Mass., July 09, 2026--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) today announced a regular quarterly cash distribution on its common shares of $0.01 per share ($0.04 per share per year). This distribution will be paid to DHC’s common shareholders of record as of the close of business on July 20, 2026 and distributed on or about August 13, 2026. About Diversified Healthcare Trust: DHC is a real estate investment trust focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of March 31, 2026, DHC’s approximately $6.2 billion portfolio included 285 properties in 33 states and Washington, D.C., with 23,901 senior living units, approximately 5.6 million square feet of medical office and life science properties and occupied by approximately 250 tenants. DHC is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with over $37 billion in assets under management as of March 31, 2026 and 40 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquartered in Newton, MA. For more information, visit www.dhcreit.com. WARNING CONCERNING FORWARD-LOOKING STATEMENTS This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws. These forward-looking statements are based upon DHC’s present intent, beliefs and expectations, but these statements and the implications of these statements are not guaranteed to occur and may not occur for various reasons, some of which are beyond DHC’s control. For example, this press release states that DHC’s regular quarterly cash distribution rate is $0.01 per share per quarter or $0.04 per share per year. A possible implication of this statement is that DHC will continue to pay quarterly distributions of $0.01 per share per quarter or $0.04 per share per year in the future. DHC’s distribution rate may be set and reset from time to time by DHC’s Board of Trustees. DHC’s Board of Trustees considers many factors when setting or resetting DHC’s distribution rate, including DHC’s funds from operations and normalized funds from operatio…Read full documentShow less
NEWTON, Mass., July 09, 2026--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) today announced a regular quarterly cash distribution on its common shares of $0.01 per share ($0.04 per share per year). This distribution will be paid to DHC’s common shareholders of record as of the close of business on July 20, 2026 and distributed on or about August 13, 2026. About Diversified Healthcare Trust: DHC is a real estate investment trust focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of March 31, 2026, DHC’s approximately $6.2 billion portfolio included 285 properties in 33 states and Washington, D.C., with 23,901 senior living units, approximately 5.6 million square feet of medical office and life science properties and occupied by approximately 250 tenants. DHC is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with over $37 billion in assets under management as of March 31, 2026 and 40 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquartered in Newton, MA. For more information, visit www.dhcreit.com. WARNING CONCERNING FORWARD-LOOKING STATEMENTS This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws. These forward-looking statements are based upon DHC’s present intent, beliefs and expectations, but these statements and the implications of these statements are not guaranteed to occur and may not occur for various reasons, some of which are beyond DHC’s control. For example, this press release states that DHC’s regular quarterly cash distribution rate is $0.01 per share per quarter or $0.04 per share per year. A possible implication of this statement is that DHC will continue to pay quarterly distributions of $0.01 per share per quarter or $0.04 per share per year in the future. DHC’s distribution rate may be set and reset from time to time by DHC’s Board of Trustees. DHC’s Board of Trustees considers many factors when setting or resetting DHC’s distribution rate, including DHC’s funds from operations and normalized funds from operations, cash available for distribution, requirements to maintain DHC’s qualification for taxation as a REIT, the then current and expected needs and availability of cash to pay DHC’s obligations and fund its investments, limitations in DHC’s debt agreements, the availability to DHC of debt and equity capital, DHC’s dividend yield and its dividend yield compared to the dividend yields of other REITs, DHC’s expectation of its future capital requirements and operating performance, DHC’s expected needs for and availability of cash to pay its obligations and other factors deemed relevant by DHC’s Board of Trustees in its discretion. Accordingly, future distributions to DHC’s shareholders may be increased or decreased and DHC cannot be sure as to the rate at which future distributions will be paid. You should not place undue reliance upon forward-looking statements. Except as required by law, DHC does not intend to update or change any forward-looking statements as a result of new information, future events or otherwise. A Maryland Real Estate Investment Trust with transferable shares of beneficial interest listed on the Nasdaq.No shareholder, Trustee or officer is personally liable for any act or obligation of the Trust. View source version on businesswire.com: https://www.businesswire.com/news/home/20260708530400/en/ Contacts Bryan Maher, Senior Vice President(617) 796-8234
Investor releaseQuarter not tagged2026-07-06Diversified Healthcare Trust Second Quarter 2026 Conference Call Scheduled for Tuesday, August 4th
Business Wire
Diversified Healthcare Trust Second Quarter 2026 Conference Call Scheduled for Tuesday, August 4th
NEWTON, Mass., July 06, 2026--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) today announced that it will issue a press release containing its second quarter 2026 financial results after the Nasdaq closes on Monday, August 3, 2026. On Tuesday, August 4, 2026 at 10:00 a.m. Eastern Time, President and Chief Executive Officer Chris Bilotto, Chief Financial Officer and Treasurer Matthew Brown and Vice President Anthony Paula will host a conference call to discuss these results. The conference call telephone number is (877) 329-4297. Participants calling from outside the United States and Canada should dial (412) 317-5435. No pass code is necessary to access the call from either number. Participants should dial in about 15 minutes prior to the scheduled start of the call. A replay of the conference call will be available through 11:59 p.m. Eastern Time on Tuesday, August 11, 2026. To hear the replay, dial (855) 669-9658. The replay pass code is 4724843. A live audio webcast of the conference call will also be available in a listen-only mode on the company’s website, which is located at www.dhcreit.com. Participants wanting to access the webcast should visit the company’s website about five minutes before the call. The archived webcast will be available for replay on the company’s website after the call. About Diversified Healthcare Trust DHC is a real estate investment trust focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of March 31, 2026, DHC’s approximately $6.2 billion portfolio included 285 properties in 33 states and Washington, D.C., with 23,901 senior living units, approximately 5.6 million square feet of medical office and life science properties and occupied by approximately 250 tenants. DHC is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with over $37 billion in assets under management as of March 31, 2026 and 40 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquartered in Newton, MA. For more information, visit www.dhcreit.com. A Maryland Real Estate Investment Trust with transferable shares of beneficial interest list…Read full documentShow less
NEWTON, Mass., July 06, 2026--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) today announced that it will issue a press release containing its second quarter 2026 financial results after the Nasdaq closes on Monday, August 3, 2026. On Tuesday, August 4, 2026 at 10:00 a.m. Eastern Time, President and Chief Executive Officer Chris Bilotto, Chief Financial Officer and Treasurer Matthew Brown and Vice President Anthony Paula will host a conference call to discuss these results. The conference call telephone number is (877) 329-4297. Participants calling from outside the United States and Canada should dial (412) 317-5435. No pass code is necessary to access the call from either number. Participants should dial in about 15 minutes prior to the scheduled start of the call. A replay of the conference call will be available through 11:59 p.m. Eastern Time on Tuesday, August 11, 2026. To hear the replay, dial (855) 669-9658. The replay pass code is 4724843. A live audio webcast of the conference call will also be available in a listen-only mode on the company’s website, which is located at www.dhcreit.com. Participants wanting to access the webcast should visit the company’s website about five minutes before the call. The archived webcast will be available for replay on the company’s website after the call. About Diversified Healthcare Trust DHC is a real estate investment trust focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of March 31, 2026, DHC’s approximately $6.2 billion portfolio included 285 properties in 33 states and Washington, D.C., with 23,901 senior living units, approximately 5.6 million square feet of medical office and life science properties and occupied by approximately 250 tenants. DHC is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with over $37 billion in assets under management as of March 31, 2026 and 40 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquartered in Newton, MA. For more information, visit www.dhcreit.com. A Maryland Real Estate Investment Trust with transferable shares of beneficial interest listed on the Nasdaq.No shareholder, Trustee or officer is personally liable for any act or obligation of the Trust. View source version on businesswire.com: https://www.businesswire.com/news/home/20260706101738/en/ Contacts Bryan Maher, Senior Vice President(617) 796-8234
Investor releaseQuarter not tagged2026-06-23RBC Capital Sees Healthy Earnings Growth Ahead for Diversified Healthcare Trust (DHC)
Insider Monkey
RBC Capital Sees Healthy Earnings Growth Ahead for Diversified Healthcare Trust (DHC)
Diversified Healthcare Trust (NASDAQ:DHC) is included among the 13 Best Dividend Stocks to Buy Under $25. On June 18, RBC Capital raised its price recommendation on Diversified Healthcare Trust (NASDAQ:DHC) to $8 from $6. It reiterated a Sector Perform rating on the shares. Analyst Michael Carroll said the company has made solid progress repositioning its in-place SHOP portfolio and has become more active in pursuing revenue-generating projects. In a research note to investors, the firm said these efforts should support healthy earnings growth over the next few years. Earlier, on June 9, B. Riley raised its price goal on DHC to $11 from $8.50. It maintained a Buy rating on the stock following a guidance increase ahead of the Nareit REITweek Conference. The analyst said the updated guidance was driven by better-than-expected expense savings. As a result, B. Riley believes the runway for “robust NOI” could extend well beyond 2026. Diversified Healthcare Trust (NASDAQ:DHC) is a real estate investment trust (REIT) focused on owning healthcare properties across the United States. While we acknowledge the potential of DHC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 12 Ultra-High Dividend Stocks to Buy for Income Investors and Top 12 Dividend Stocks to Buy According to Billionaire Cliff Asness Disclosure: None. Follow Insider Monkey on Google News.
Investor releaseQuarter not tagged2026-05-09The RMR Group Q2 Earnings Call Highlights
MarketBeat
The RMR Group Q2 Earnings Call Highlights
Interested in The RMR Group Inc.? Here are five stocks we like better. The RMR Group said fiscal Q2 2026 results came in at or above the high end of guidance, with distributable earnings of $0.44 per share and Adjusted EBITDA of $18.5 million. Management also said the company earned $23.6 million in incentive fees for 2025 and expects more incentive fees this year. RMR highlighted progress at its managed REITs, including stronger operating trends at Diversified Healthcare Trust, a major deleveraging move at Service Properties Trust, and better-than-expected results and refinancing at Industrial Logistics Properties Trust. Office Properties Income Trust also received court approval for its reorganization plan and is expected to emerge from bankruptcy by the end of the quarter. The company said its private capital platform has grown to nearly $12 billion in assets under management, even as fundraising remains challenged by geopolitical uncertainty. RMR also entered the Greenwich multifamily market with a roughly $350 million acquisition, and management guided for Q3 distributable earnings of $0.48 to $0.50 per share. The RMR Group (NASDAQ:RMR) reported fiscal second-quarter 2026 results at or above the high end of its outlook, as management highlighted incentive fees from managed REITs, ongoing private capital fundraising efforts and recent balance sheet investments. President and CEO Adam Portnoy said RMR generated distributable earnings of $0.44 per share and Adjusted EBITDA of $18.5 million for the quarter. He said the results came “despite operating in what remains an unsettled economic environment,” citing market volatility and geopolitical uncertainty. → Insider Sales: Top AST SpaceMobile Insider Cuts Postion Over 30% RMR earned $23.6 million of incentive fees for 2025, and Portnoy said the company is on track to earn incentive fees again this year, with both Diversified Healthcare Trust and Industrial Logistics Properties Trust accruing incentive fees during the quarter. Portnoy reviewed several developments across RMR’s managed REITs, saying the company has been active in executing clients’ strategic initiatives. → Light Speed Returns: Corning Cashes In on NVIDIA Growth At Diversified Healthcare Trust, or DHC, Portnoy said the company has focused on improving senior housing operating performance after transitioning 116 senior living communities to new…Read full documentShow less
Interested in The RMR Group Inc.? Here are five stocks we like better. The RMR Group said fiscal Q2 2026 results came in at or above the high end of guidance, with distributable earnings of $0.44 per share and Adjusted EBITDA of $18.5 million. Management also said the company earned $23.6 million in incentive fees for 2025 and expects more incentive fees this year. RMR highlighted progress at its managed REITs, including stronger operating trends at Diversified Healthcare Trust, a major deleveraging move at Service Properties Trust, and better-than-expected results and refinancing at Industrial Logistics Properties Trust. Office Properties Income Trust also received court approval for its reorganization plan and is expected to emerge from bankruptcy by the end of the quarter. The company said its private capital platform has grown to nearly $12 billion in assets under management, even as fundraising remains challenged by geopolitical uncertainty. RMR also entered the Greenwich multifamily market with a roughly $350 million acquisition, and management guided for Q3 distributable earnings of $0.48 to $0.50 per share. The RMR Group (NASDAQ:RMR) reported fiscal second-quarter 2026 results at or above the high end of its outlook, as management highlighted incentive fees from managed REITs, ongoing private capital fundraising efforts and recent balance sheet investments. President and CEO Adam Portnoy said RMR generated distributable earnings of $0.44 per share and Adjusted EBITDA of $18.5 million for the quarter. He said the results came “despite operating in what remains an unsettled economic environment,” citing market volatility and geopolitical uncertainty. → Insider Sales: Top AST SpaceMobile Insider Cuts Postion Over 30% RMR earned $23.6 million of incentive fees for 2025, and Portnoy said the company is on track to earn incentive fees again this year, with both Diversified Healthcare Trust and Industrial Logistics Properties Trust accruing incentive fees during the quarter. Portnoy reviewed several developments across RMR’s managed REITs, saying the company has been active in executing clients’ strategic initiatives. → Light Speed Returns: Corning Cashes In on NVIDIA Growth At Diversified Healthcare Trust, or DHC, Portnoy said the company has focused on improving senior housing operating performance after transitioning 116 senior living communities to new operators in the second half of 2025. DHC generated first-quarter Normalized FFO of $33 million, or $0.14 per share, and Adjusted EBITDA of $74 million, both above analyst consensus estimates, according to Portnoy. Same-property NOI in the senior housing operating portfolio rose 13.5% year over year, while occupancy increased 110 basis points. DHC also sold 13 unencumbered non-core communities in March for gross proceeds of approximately $23 million. Portnoy said asset sales are expected to slow in 2026 after DHC completed about $605 million of sales in 2025, with management now focused on improving NOI in the retained portfolio. He also noted that Moody’s upgraded DHC’s debt ratings in April and revised its outlook to positive from stable. → Years in the Making, AMD’s Upside Movement Has Just Begun At Service Properties Trust, or SVC, Portnoy said RMR helped complete a $575 million equity offering that accelerated deleveraging, eliminated near-term refinancing risk and provided flexibility to improve hotel performance and pursue additional asset sales. RMR participated in the offering with a $50 million anchor investment. Portnoy said the proceeds allowed SVC to eliminate all unsecured debt maturities until 2028. For Industrial Logistics Properties Trust, or ILPT, Portnoy said first-quarter Normalized FFO of $0.33 per share and Adjusted EBITDA of $87 million exceeded the high end of management’s guidance. ILPT completed about 862,000 square feet of leasing during the quarter at rental rates 26% above prior rents. RMR also assisted ILPT with the refinancing of $1.6 billion of debt for its consolidated Mountain Joint Venture, replacing floating-rate and amortizing debt with interest-only fixed-rate debt at a 5.7% rate. Seven Hills Realty Trust originated three loans totaling $67.5 million during the quarter and generated distributable earnings of $0.24 per share, Portnoy said. Total loan commitments reached approximately $776 million, a record high for the portfolio. Portnoy also said Office Properties Income Trust, or OPI, received court approval for its plan of reorganization and is expected to emerge from bankruptcy by the end of the fiscal second quarter. He said RMR expects to continue managing OPI under previously disclosed terms, including a five-year term and a flat business management fee of $14 million per year for the first two years, while property management economics remain unchanged. Chief Operating Officer Matt Jordan said RMR’s private capital business has grown from “essentially zero” assets under management in 2020 to nearly $12 billion today. He said RMR is building brand awareness with global investors and has met with nearly 200 global investors representing almost $7 trillion in assets under management. Jordan said fundraising has been disrupted by the ongoing conflict in the Middle East, with global fundraising in the first quarter of 2026 down 50% from the prior year. However, he said North American real estate still attracted 65% of all dollars raised, and value-add strategies accounted for 56% of fundraising. RMR’s residential business now represents more than $4.7 billion in value-add residential real estate across 18,500 owned and managed units, Jordan said. In April, RMR closed on the acquisition of a multifamily portfolio in Greenwich, Connecticut, for almost $350 million. The transaction was sourced off-market and marks RMR’s entry into what Jordan described as one of the country’s most supply-constrained and affluent housing markets. RMR Residential will manage the properties and pursue a multiyear strategy to modernize communities, enhance the resident experience and improve efficiencies. The acquisition was completed through a joint venture in which RMR is a co-general partner and invested $6 million for a 5% ownership interest. Jordan said the remaining approximately $120 million of equity was raised from two institutional partners. RMR expects to recognize $600,000 of revenue from the transaction in fiscal Q3 and earn ongoing operating fees of about $750,000 annually. Jordan said the venture is expected to generate annual cash-on-cash returns of approximately 7.5% over the longer term, with potential carried interest as investment hurdles are met. Chief Financial Officer Matt Brown said recurring service revenues were $42 million in the quarter, down about $1 million sequentially, primarily due to hotel sales, lower enterprise values at SVC and DHC as those companies paid down debt, and the wind-down of AlerisLife’s business. Brown said RMR expects recurring service revenues to rise to about $44 million next quarter, driven by revenue from the Greenwich acquisition, higher construction management fees and enterprise value improvements at certain managed REITs. Recurring cash compensation was $37.7 million, up modestly from the prior quarter due to payroll tax and benefit resets, and is expected to remain consistent in fiscal Q3. Recurring general and administrative expense was $10.1 million, excluding $600,000 in annual director share grants, and is expected to remain around that level for the rest of the fiscal year. For fiscal Q3, Brown guided for Adjusted EBITDA of approximately $19 million to $21 million and distributable earnings of $0.48 to $0.50 per share. He said RMR will no longer provide guidance for adjusted net income because investments in leveraged real estate have reduced the metric’s usefulness due to depreciation and interest expense. Brown said RMR’s current liquidity is approximately $133 million, including $75 million of capacity on its revolving credit facility, after the $50 million SVC investment and the $6 million Greenwich joint venture investment. The SVC investment is expected to generate about $420,000 of incremental quarterly dividends. During the question-and-answer session, Portnoy said RMR’s multifamily investments are likely to remain private and continue to be structured through joint ventures and small portfolio investments. He said RMR is also trying to build a dedicated fund around the strategy, but he does not expect a transaction that would roll up the full $4.7 billion multifamily portfolio into a public vehicle. Portnoy said development and credit remain priorities, though development is difficult in the current market because of uncertainty and elevated required returns. He said Seven Hills has close to $500 million of capacity for new investments over the next year, supported by new capital and expected loan payoffs. Asked about RMR’s cash position, Portnoy said the company remains “all systems go” for the right opportunities, with more than $100 million of liquidity between cash and revolver capacity. He added that RMR is optimistic it could recover cash if it successfully syndicates its Enhanced Growth Venture tied to the multifamily strategy. Jordan said fundraising for equity remains challenging, with geopolitical volatility slowing conversations with investors. He said allocations to real estate remain in place over the long term, but fundraising cycles are taking longer. The RMR Group, Inc (NASDAQ: RMR) is a publicly traded asset management company that specializes in providing comprehensive real estate and investment management services to both public and private entities. Acting as an external manager, RMR offers a range of services encompassing property management, asset management, fund administration, accounting, investor relations and compliance oversight. Its client base includes real estate investment trusts (REITs), real estate operating companies (REOCs), closed-end real estate funds and institutional investors. Founded in 1986, RMR Group has built a business model centered on recurring fee revenue generated through long-term service agreements with its managed entities. The article "The RMR Group Q2 Earnings Call Highlights" was originally published by MarketBeat. View MarketBeat's top stocks for May 2026.
Investor releaseQuarter not tagged2026-05-05Diversified Healthcare Trust Announces First Quarter 2026 Results
Business Wire
Diversified Healthcare Trust Announces First Quarter 2026 Results
NEWTON, Mass., May 04, 2026--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) today announced its financial results for the quarter ended March 31, 2026, which can be found at the Quarterly Reports section of DHC's website at https://www.dhcreit.com/investors/financial-information/quarterly/default.aspx. A conference call to discuss DHC's first quarter 2026 financial results will be held on Tuesday, May 5, 2026 at 10:00 a.m. Eastern Time. The conference call may be accessed by dialing (877) 329-4297 or (412) 317-5435 (if calling from outside the United States and Canada); a pass code is not required. A replay will be available for one week by dialing (855) 669-9658; the replay pass code is 1482489. A live audio webcast of the conference call will also be available in a listen-only mode on DHC's website, at www.dhcreit.com. The archived webcast will be available for replay on DHC's website after the call. The transcription, recording and retransmission in any way of DHC's first quarter conference call are strictly prohibited without the prior written consent of DHC. About Diversified Healthcare Trust: DHC is a real estate investment trust focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of March 31, 2026, DHC’s approximately $6.2 billion portfolio included 285 properties in 33 states and Washington, D.C., with 23,901 senior living units, approximately 5.6 million square feet of medical office and life science properties and occupied by approximately 250 tenants. DHC is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with over $37 billion in assets under management as of March 31, 2026 and 40 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquartered in Newton, MA. For more information, visit www.dhcreit.com. A Maryland Real Estate Investment Trust with transferable shares of beneficial interest listed on the Nasdaq. No shareholder, Trustee or officer is personally liable for any act or obligation of the Trust. View source version on businesswire.com: https://www.businesswire.com/news/home/20260504286881/en/ Contacts Bryan Maher, Seni…Read full documentShow less
NEWTON, Mass., May 04, 2026--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) today announced its financial results for the quarter ended March 31, 2026, which can be found at the Quarterly Reports section of DHC's website at https://www.dhcreit.com/investors/financial-information/quarterly/default.aspx. A conference call to discuss DHC's first quarter 2026 financial results will be held on Tuesday, May 5, 2026 at 10:00 a.m. Eastern Time. The conference call may be accessed by dialing (877) 329-4297 or (412) 317-5435 (if calling from outside the United States and Canada); a pass code is not required. A replay will be available for one week by dialing (855) 669-9658; the replay pass code is 1482489. A live audio webcast of the conference call will also be available in a listen-only mode on DHC's website, at www.dhcreit.com. The archived webcast will be available for replay on DHC's website after the call. The transcription, recording and retransmission in any way of DHC's first quarter conference call are strictly prohibited without the prior written consent of DHC. About Diversified Healthcare Trust: DHC is a real estate investment trust focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of March 31, 2026, DHC’s approximately $6.2 billion portfolio included 285 properties in 33 states and Washington, D.C., with 23,901 senior living units, approximately 5.6 million square feet of medical office and life science properties and occupied by approximately 250 tenants. DHC is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with over $37 billion in assets under management as of March 31, 2026 and 40 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquartered in Newton, MA. For more information, visit www.dhcreit.com. A Maryland Real Estate Investment Trust with transferable shares of beneficial interest listed on the Nasdaq. No shareholder, Trustee or officer is personally liable for any act or obligation of the Trust. View source version on businesswire.com: https://www.businesswire.com/news/home/20260504286881/en/ Contacts Bryan Maher, Senior Vice President (617) 796-8234
Investor releaseQuarter not tagged2026-05-05Diversified Healthcare Trust Q1 Earnings Call Highlights
MarketBeat
Diversified Healthcare Trust Q1 Earnings Call Highlights
Operational outperformance: DHC reported Q1 Normalized FFO of $33.1M ($0.14/share) and Adjusted EBITDAre of $74M, both above consensus, with same-property SHOP NOI up 13.5% YoY as occupancy reached 82.4% and average monthly rates rose roughly 5.9%. Expense controls and new operator partnerships drove meaningful savings—dietary costs fell 370 basis points sequentially, contract labor was down nearly 35% YoY, and labor costs declined about 70 basis points sequentially—supporting margin expansion. Balance-sheet and capital priorities: liquidity totaled $272M (cash $122M, $150M revolver), net debt/Adjusted EBITDAre improved to 7.8x, Moody’s upgraded to B3 with a positive outlook and no maturities until 2028, management reaffirmed 2026 guidance and is focusing on accretive conversions (phase one ~$20M to add ~150 units) to target mid‑teen returns and a 6.5–7.5x leverage goal. Interested in Diversified Healthcare Trust? Here are five stocks we like better. Diversified Healthcare Trust (NASDAQ:DHC) reported first-quarter 2026 results that management said reflected improving operating performance following strategic changes made in its senior housing operating portfolio last year, alongside continued progress on balance sheet initiatives. President and CEO Christopher Bilotto said the company “delivered a strong first quarter” that highlighted the impact of “active asset management and the deep expertise of our expanded operating partners.” He said changes made within the company’s SHOP (senior housing operating portfolio) in 2025 continued to produce results, with a focus on “driving revenue, expense synergies, and overall margin improvement.” → Roblox Stock Slides to New Low as Safety Changes Weigh on Outlook DHC reported Normalized funds from operations (FFO) of $33.1 million, or $0.14 per share, and Adjusted EBITDAre of $74 million. Bilotto said both were “well ahead of the analyst consensus estimate.” Consolidated net operating income (NOI) rose 4.7% year over year to $75.9 million. The company’s same-property SHOP portfolio posted NOI of $44.3 million, up 13.5% year over year. Bilotto attributed the improvement to same-property occupancy growth of 110 basis points and average monthly rate growth of 5.9%. He also said same-property NOI margin expanded 160 basis points to 14.9%, with occupancy at 82.4%. → The Real SpaceX Play: 5 Chip Stocks Powering the IPO Befo…Read full documentShow less
Operational outperformance: DHC reported Q1 Normalized FFO of $33.1M ($0.14/share) and Adjusted EBITDAre of $74M, both above consensus, with same-property SHOP NOI up 13.5% YoY as occupancy reached 82.4% and average monthly rates rose roughly 5.9%. Expense controls and new operator partnerships drove meaningful savings—dietary costs fell 370 basis points sequentially, contract labor was down nearly 35% YoY, and labor costs declined about 70 basis points sequentially—supporting margin expansion. Balance-sheet and capital priorities: liquidity totaled $272M (cash $122M, $150M revolver), net debt/Adjusted EBITDAre improved to 7.8x, Moody’s upgraded to B3 with a positive outlook and no maturities until 2028, management reaffirmed 2026 guidance and is focusing on accretive conversions (phase one ~$20M to add ~150 units) to target mid‑teen returns and a 6.5–7.5x leverage goal. Interested in Diversified Healthcare Trust? Here are five stocks we like better. Diversified Healthcare Trust (NASDAQ:DHC) reported first-quarter 2026 results that management said reflected improving operating performance following strategic changes made in its senior housing operating portfolio last year, alongside continued progress on balance sheet initiatives. President and CEO Christopher Bilotto said the company “delivered a strong first quarter” that highlighted the impact of “active asset management and the deep expertise of our expanded operating partners.” He said changes made within the company’s SHOP (senior housing operating portfolio) in 2025 continued to produce results, with a focus on “driving revenue, expense synergies, and overall margin improvement.” → Roblox Stock Slides to New Low as Safety Changes Weigh on Outlook DHC reported Normalized funds from operations (FFO) of $33.1 million, or $0.14 per share, and Adjusted EBITDAre of $74 million. Bilotto said both were “well ahead of the analyst consensus estimate.” Consolidated net operating income (NOI) rose 4.7% year over year to $75.9 million. The company’s same-property SHOP portfolio posted NOI of $44.3 million, up 13.5% year over year. Bilotto attributed the improvement to same-property occupancy growth of 110 basis points and average monthly rate growth of 5.9%. He also said same-property NOI margin expanded 160 basis points to 14.9%, with occupancy at 82.4%. → The Real SpaceX Play: 5 Chip Stocks Powering the IPO Before It Launches Bilotto said revenue gains were supported by an average annual rate increase of 4.5% across 70% of the SHOP portfolio in January, as well as “a favorable shift in resident levels of care.” On the cost side, he said DHC’s new operator partnerships were helping to drive savings, citing new dietary and food and beverage contracts that improved the resident experience while “locking in significant cost savings for the year.” He also said labor costs were moderating due to reduced contract labor and rightsizing of regional and community staffing. Vice President Anthony Paula provided additional detail on expense trends, noting that within the same-property SHOP portfolio the quarter included: A 370 basis point decrease in dietary costs sequentially, A 70 basis point sequential reduction in labor (adjusting for the number of days in the period), and A nearly 35% decrease in contract labor year over year. → 3 Emerging Markets ETFs to Maximize Exposure to High-Potential Countries Paula said same-property average monthly rate increased 590 basis points year over year and 320 basis points sequentially. He added that consolidated same-property cash basis NOI was $75.9 million, up 8.6% year over year and 7.8% sequentially, and that SHOP same-property NOI would have increased 22% year over year when adjusting for insurance proceeds received in the first quarter of 2025. In the Q&A, management discussed quarter-over-quarter flat SHOP occupancy. Bilotto said the result reflected both seasonality and the effects of operator transitions, adding that “given the fact that we can hold occupancy while we're going through a major transition across the entire portfolio, I think is a real win.” He said the company expected to focus on occupancy growth as it enters seasonally stronger periods, but did not provide specific second-quarter figures, noting April results were still being finalized. DHC also reported what Bilotto described as “solid results” in its medical office and life science portfolio. Same-property occupancy rose 60 basis points year over year to 95.3%, and NOI increased 3.7% from the prior year to $25.4 million, along with a 4.8% sequential increase. Leasing activity included 169,000 square feet of new and renewal leases at rents 12% above prior rents and a 9.5-year weighted average lease term, according to Bilotto. He said just over 9% of analyzed rental income in the segment is scheduled to expire through 2026, with 304,000 square feet—about 4.9% of annualized rental income—expected to vacate. He also noted that after quarter-end the company signed 390,000 square feet of leases, primarily renewals, representing 29% of its 2027 expirations. Bilotto said DHC is increasingly focused on selectively deploying capital into what he described as higher-return projects, including converting underutilized or closed skilled nursing wings into independent living, assisted living, or memory care. He said the company identified opportunities across 16 communities, with six communities in a first phase expected to cost about $20 million and add roughly 150 units. Bilotto said DHC currently absorbs carrying costs on the vacant wings, and the projects are expected to be “immediately accretive” upon completion, with expected returns “starting in the mid-teens.” On portfolio and balance sheet actions, Bilotto said DHC sold 13 unencumbered non-core SHOP communities in March for aggregate proceeds of $23 million. He also said the company exercised land lease purchase options on two properties in April for $14.5 million, and expects “low to mid-teen returns” from eliminating ground rent on those communities. Bilotto added that with its “large-scale capital recycling program now complete,” DHC has shifted from portfolio transformation “to value creation,” and he emphasized the company’s debt profile includes “no maturities until 2028.” Chief Financial Officer Matthew Brown said total liquidity at quarter-end was $272 million, including $122 million of cash and cash equivalents and $150 million available under a secured revolving credit facility. Net debt to annualized Adjusted EBITDAre was 7.8 times, down from 8.8 times a year ago, which Brown said was driven primarily by improved operating performance. Adjusted EBITDAre to interest expense improved to 2.0 times from 1.3 times a year earlier. Brown said DHC remained confident in reaching a near-term leverage target of 6.5–7.5 times, with most improvement expected from continued growth in SHOP NOI. Brown also noted that Moody’s upgraded DHC’s corporate family rating to B3 from Caa1 in April and revised its outlook to positive, citing progress in operations and balance sheet strengthening. He added that DHC has 197 unencumbered properties, representing nearly 64% of the portfolio’s gross book value. For full-year 2026, Brown said DHC reaffirmed guidance ranges previously outlined in its fourth-quarter earnings, including: $175 million–$185 million of SHOP NOI, $94 million–$98 million of medical office and life science segment NOI, $28 million–$30 million of NOI from triple net lease senior living communities and wellness centers, Adjusted EBITDAre of $290 million–$305 million, and Normalized FFO of $0.52–$0.58 per share. Paula said first-quarter general and administrative expense included $6.6 million of incentive management fees due to stock performance; excluding the incentive fee, G&A expense would have been $7.4 million. He also said DHC invested $21.8 million of capital during the quarter—$17.2 million in SHOP communities and $4.6 million in the medical office and life science portfolio—and reaffirmed 2026 recurring capital expenditure guidance of $100 million to $115 million, which he said represented an approximately 18% reduction at the midpoint. In response to analyst questions, management said recurring CapEx in SHOP includes both maintenance and some “refresh” capital, and indicated the per-unit maintenance run rate is expected to decline in future periods. Bilotto said new investment activity is expected to be “mostly the renovations” within the portfolio, rather than acquisitions, as the company prioritizes internal opportunities. Diversified Healthcare Trust is a real estate investment trust (REIT) specializing in the acquisition, ownership and management of healthcare properties across the United States. The company focuses on assets that serve the senior housing and post-acute care sectors, including skilled nursing facilities, assisted living communities, memory care centers and medical office buildings. By partnering with experienced operators, Diversified Healthcare Trust aims to generate stable, long-term cash flows through triple-net leases and percentage rent structures tailored to each property type. The company's portfolio spans multiple states and encompasses a mix of single-tenant and multi-tenant properties. The article "Diversified Healthcare Trust Q1 Earnings Call Highlights" was originally published by MarketBeat.

